3.0.0 1269 2025-05-27T14:16:45Z 2025-05-27T14:16:45Z Senate S S 2023-04-25 118 sshr00 Health, Education, Labor, and Pensions Committee Senate Standing Referred To 2023-04-25T20:28:23Z 118 1067 S 2023-06-22 Placed on Senate Legislative Calendar under General Orders. Calendar No. 107. Related bill CRS 118 5372 HR 2023-12-06 Ordered to be Reported (Amended) by the Yeas and Nays: 48 - 0. Related bill CRS 2023-04-25 sshr00 Health, Education, Labor, and Pensions Committee Senate Read twice and referred to the Committee on Health, Education, Labor, and Pensions. IntroReferral 2023-04-25 Introduced in Senate IntroReferral 10000 9 Library of Congress S001181 Sen. Shaheen, Jeanne [D-NH] Jeanne Shaheen D NH N C001035 Sen. Collins, Susan M. [R-ME] Susan Collins R ME M. 2023-04-25 True S000770 Sen. Stabenow, Debbie [D-MI] Debbie Stabenow D MI 2023-06-22 False B001319 Sen. Britt, Katie Boyd [R-AL] Katie Britt R AL 2023-06-22 False T000464 Sen. Tester, Jon [D-MT] Jon Tester D MT 2023-06-22 False T000278 Sen. Tuberville, Tommy [R-AL] Tommy Tuberville R AL 2023-06-22 False K000377 Sen. Kelly, Mark [D-AZ] Mark Kelly D AZ 2023-09-19 False W000437 Sen. Wicker, Roger F. [R-MS] Roger Wicker R MS F. 2023-09-19 False R000608 Sen. Rosen, Jacky [D-NV] Jacklyn Rosen D NV 2023-10-04 False M001153 Sen. Murkowski, Lisa [R-AK] Lisa Murkowski R AK 2023-10-04 False K000383 Sen. King, Angus S., Jr. [I-ME] Angus King I ME S. 2023-11-02 False B001310 Sen. Braun, Mike [R-IN] Mike Braun R IN 2023-11-02 False B001230 Sen. Baldwin, Tammy [D-WI] Tammy Baldwin D WI 2023-11-09 False G000386 Sen. Grassley, Chuck [R-IA] Chuck Grassley R IA 2023-11-09 False Health Health 2023-05-08T19:30:20Z

00 2023-04-25 Introduced in Senate 2024-03-30T00:55:02Z <p><b>Improving Needed Safeguards for Users of Lifesaving Insulin Now Act of 2023 or the INSULIN Act of 2023</b></p> <p>This bill limits cost-sharing for insulin under private health insurance and revises the requirements for approval and cost-sharing of generic drugs and biosimilar products.</p> <p>Specifically, the bill caps cost-sharing under private health insurance for a month's supply of selected insulin products at $35 or 25% of a plan's negotiated price (after any price concessions), whichever is less, beginning in 2025.</p> <p>The bill also requires pharmacy benefit managers (PBMs) to remit to the group health plan 100% of the fees, alternative discounts, and all other remuneration received from a drug manufacturer.</p> <p>Additionally, the bill modifies the Food and Drug Administration's (FDA) procedures for determining whether a petition to delay the approval of a generic drug was made with the primary purpose of delaying the application and provides for the referral of such petitions to the Federal Trade Commission. The bill also authorizes the FDA to expedite the development and review of applications for products designated as a competitive biosimilar therapy.</p> <p>Finally, the bill permits prescription drug plan sponsors under Medicare Part D to make certain mid-year changes to the cost-sharing tier of a reference biological product if the sponsor also adds the respective biosimilar product to the same or a lower cost-sharing tier as the reference biological product immediately prior to the change.</p>

Display Title 45 2024-07-24T15:22:34Z Short Title(s) as Introduced 101 2024-05-24T13:40:41Z Introduced in Senate IS Short Title(s) as Introduced 101 2024-05-24T13:40:41Z Introduced in Senate IS Official Title as Introduced 6 2024-04-02T08:08:15Z Introduced in Senate IS Introduced in Senate 2023-04-25T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-118s1269is/xml/BILLS-118s1269is.xml 2023-04-25 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.